Why We Care
Founded by patients for patients, The MPN Research Foundation has established strong relationships with top researchers, clinicians and biopharmaceutical companies to get us closer to a cure for myeloproliferative neoplasms (MPNs), particularly polycythemia vera, primary myelofibrosis and essential thrombocythemia.
2010 was a year of major breakthroughs in MPN science, with the advancement of clinical trials that may result, as early as 2011, in the first new treatments for MPN patients in decades. To date, the Foundation has awarded over eight million dollars for MPN research.
As a small patient-driven organization, terms on every research grant are negotiated to maximize the dollars invested in actual research, with approximately 80% of the funds raised are channeled directly into supporting myeloproliferative neoplasm research. The Foundation’s esteemed Scientific Advisory Board utilizes a rigorous selection process to ensure donations are allocated to the most innovative research projects. The scientific advisory board includes highly regarded physicians from Scripps, University of Utah, BC Cancer Research Center and Weill Cornell.
To make a donation to the MPN Research Foundation, click here.